Matches in Wikidata for { <http://www.wikidata.org/entity/Q64173538> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q64173538 description "clinical trial" @default.
- Q64173538 description "ensayu clínicu" @default.
- Q64173538 description "klinisch onderzoek" @default.
- Q64173538 description "клінічне випробування" @default.
- Q64173538 description "կլինիկական փորձարկում" @default.
- Q64173538 name "Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors" @default.
- Q64173538 type Item @default.
- Q64173538 label "Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors" @default.
- Q64173538 prefLabel "Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors" @default.
- Q64173538 P1132 Q64173538-401B9B7C-69A2-4EB9-BE73-FA433A27D1E9 @default.
- Q64173538 P1476 Q64173538-06C47554-84FE-4571-A2A2-EEEA5F9D347E @default.
- Q64173538 P17 Q64173538-20A2CA50-F160-4B6C-9720-5871CF025782 @default.
- Q64173538 P17 Q64173538-55ADEF4A-E1E6-4200-B899-5B0D0B1E4289 @default.
- Q64173538 P2899 Q64173538-E7A5993B-6834-489C-96CA-A4ECD63D1091 @default.
- Q64173538 P3098 Q64173538-57445155-8C5A-4867-97EC-17E2207FCF4F @default.
- Q64173538 P31 Q64173538-0756A8F3-62C0-40D8-A7D5-85808D3E3616 @default.
- Q64173538 P4844 Q64173538-3B5A40A6-28DF-41AC-8806-9DE470672B76 @default.
- Q64173538 P580 Q64173538-CC402EE1-4B5F-4078-BC0E-06640175F2A2 @default.
- Q64173538 P582 Q64173538-C859BF7B-08A1-4F38-BE13-2FA4A1F101CE @default.
- Q64173538 P6099 Q64173538-8C096745-2B24-45BF-940D-04790CF9D880 @default.
- Q64173538 P6153 Q64173538-265199CF-0F1A-4917-B762-D9B9A7F1C9EC @default.
- Q64173538 P6153 Q64173538-6C552CB9-7075-4795-B1E1-2285DA5BA3A8 @default.
- Q64173538 P6153 Q64173538-EC8841EF-FB5E-4C38-9E88-BFFD9249D3CA @default.
- Q64173538 P6153 Q64173538-F7264072-BA8E-41A2-844D-108DA3AAD719 @default.
- Q64173538 P8363 Q64173538-0B7F3F33-8AF0-4437-86AC-976C4A0F3EBB @default.
- Q64173538 P859 Q64173538-157FBC2C-7AE4-483D-8737-5588C1B473DA @default.
- Q64173538 P1132 "+51" @default.
- Q64173538 P1476 "A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors" @default.
- Q64173538 P17 Q29 @default.
- Q64173538 P17 Q30 @default.
- Q64173538 P2899 "+18" @default.
- Q64173538 P3098 "NCT02876224" @default.
- Q64173538 P31 Q30612 @default.
- Q64173538 P4844 Q413299 @default.
- Q64173538 P580 "2016-09-30T00:00:00Z" @default.
- Q64173538 P582 "2019-08-01T00:00:00Z" @default.
- Q64173538 P6099 Q5452194 @default.
- Q64173538 P6153 Q1468161 @default.
- Q64173538 P6153 Q1808012 @default.
- Q64173538 P6153 Q3826080 @default.
- Q64173538 P6153 Q7896459 @default.
- Q64173538 P8363 Q78089383 @default.
- Q64173538 P859 Q212646 @default.